澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Osteopore

0.010

-0.001-9.09%

成交量：2,202.72萬

成交額：23.41萬

市值：432.50萬

市盈率：-0.33

高：0.012

開：0.011

低：0.010

收：0.011

52周最高：0.048

52周最低：0.006

股本：4.33億

流通股本：2.08億

量比：3.49

換手率：10.60%

股息：- -

股息率：- -

每股收益(TTM):-0.030

每股收益(LYR):-0.043

淨資產收益率：-487.52%

總資產收益率：-42.76%

市淨率：-10.21

市盈率(LYR):-0.23

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

Osteopore Ltd達成協議在中國大陸及港澳地區商業化其牙科、正畸及頜面產品

Osteopore與Accelerate Technologies簽署獨家許可協議，引進新型再生技術

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/OSX.AU"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"OSX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","market":"AU","secType":"STK","nameCN":"Osteopore","latestPrice":0.01,"timestamp":1770693456243,"preClose":0.011,"halted":0,"volume":22027240,"delay":0,"changeRate":-0.09090909090909084,"nameEN":"Osteopore","floatShares":207851789,"shares":432501807,"eps":-0.029897,"marketStatus":"交易中","change":-0.001,"latestTime":"02-10 14:32:48 AEDT","open":0.011,"high":0.012,"low":0.01,"amount":234140,"amplitude":0.181818,"askPrice":0.01,"askSize":927767,"bidPrice":0.009,"bidSize":11812008,"shortable":3,"etf":0,"ttmEps":-0.029897,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1770699600000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.011,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":3.487575,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"OSX.AU\",,,,,undefined,":{"symbol":"OSX.AU","floatShares":207851789,"roa":"-42.76%","roe":"-487.52%","lyrEps":-0.042829,"volumeRatio":3.487575,"shares":432501807,"dividePrice":0,"high":0.012,"amplitude":0.181818,"preClose":0.011,"low":0.01,"week52Low":0.006,"pbRate":"-10.21","psRate":"1.52","week52High":0.048,"institutionHeld":0,"latestPrice":0.01,"committee":0.854351,"eps":-0.029897,"divideRate":0,"volume":22027240,"delay":0,"ttmEps":-0.029897,"open":0.011,"prevYearClose":0.006,"prevWeekClose":0.009,"prevMonthClose":0.015,"prevQuarterClose":0.006,"fiveDayClose":0.012,"twentyDayClose":0.009,"sixtyDayClose":0.01,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-02-23","symbol":"OSX.AU","defaultRemindTime":1708642800000,"type":"split","dateTimestamp":1708606800000,"forFactor":15,"toFactor":1,"ratio":15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSX.AU\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182881983","title":"Osteopore Ltd達成協議 在中國大陸及港澳地區商業化其牙科、正畸及頜面產品","url":"https://stock-news.laohu8.com/highlight/detail?id=1182881983","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182881983?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 05:22","pubTimestamp":1768512155,"startTime":"0","endTime":"0","summary":"Osteopore Ltd宣布已签署一项重要商业协议，旨在将其旗下的牙科、正畸及颌面外科产品线引入中国大陆、香港和澳门市场进行商业化运营。此举标志着该公司在拓展亚太地区业务方面迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0},{"id":"1110015613","title":"Osteopore與Accelerate Technologies簽署獨家許可協議，引進新型再生技術","url":"https://stock-news.laohu8.com/highlight/detail?id=1110015613","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110015613?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 06:22","pubTimestamp":1767824569,"startTime":"0","endTime":"0","summary":"Osteopore有限公司已与Accelerate Technologies私人有限公司达成一项独家技术许可协议，旨在引进并商业化一项创新的再生技术。该协议的签署标志着Osteopore在生物材料和组织工程领域的战略布局进一步深化，有望借助Accelerate Technologies的研发实力，拓展其在医疗再生领域的产品管线。这项合作将为双方带来协同效应，加速新型再生技术的临床应用和市场推广。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7126","OSX.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":2,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OSX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}